Inspirna

Inspirna is a clinical-stage biopharmaceutical company that specializes in developing new drugs to combat cancer-related pathways. Inspire cancer medicine with RNA biology. Their founders are leading scientists from Rockefeller University, and the firm's drug development team has extensive experience in creating breakthrough medications for cancers that are notoriously difficult to treat. RNA-DRIVEr (tm), a new discovery platform created by Inspirna's founders and exclusively licensed to Inspirna, enables us to focus on first-in-class small molecule therapeutics and biologic treatments that target high-unmet cancer driver settings.